Hum Reprod Update. 2007 Jan-Feb;13(1):5-13.
Economic evaluations of single- versus double-embryo transfer in IVF.
Fiddelers AA Department of Clinical Epidemiology and Medical Technology Assessment, Research Institute Grow and Development (GROW) and Care and Public Health Research Institute (CAPHRI). Multiple pregnancies lead to complications and induce high costs. The most successful way to decrease multiple pregnancies in IVF is to transfer only one embryo, which might reduce the efficacy of treatment. The objective of this review is to determine which embryo-transfer policy is most cost-effective: elective single-embryo transfer (eSET) or double-embryo transfer (DET). Several databases were searched for (cost* or econ*) and (single embryo* or double embryo* or one embryo* or two embryo* or elect* embryo or multip* embryo*). On the basis of five exclusion criteria, titles and abstracts were screened by two individual reviewers. The remaining papers were read for further selection, and data were extracted from the selected studies. A total of 496 titles were identified through the searches and resulted in the selection of one observational study and three randomized studies. Study characteristics, total costs and probability of live births were extracted. Besides this, cost-effectiveness and incremental cost-effectiveness were derived. It can be concluded that DET is the most expensive strategy. DET is also most effective if performed in one fresh cycle. eSET is only preferred from a cost-effectiveness point of view when performed in good prognosis patients and when frozen/thawed cycles are included. If frozen/thawed cycles are excluded, the choice between eSET and DET depends on how much society is willing to pay for one extra successful pregnancy. Thank you for choosing to visit us. This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT. I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.Authors:
- Introduction
- Abortion
- Amenorrhoea
- Birth Control
- Bladder Symptoms
- Cancer in Women
- Childbirth
- Children and Teenagers
- Diet / Weight Loss
- Dysmenorrhoea
- Endometriosis
- Fibroids
- HRT
- Hirsutism
- Hysterectomy
- Infections
- Infertility
- Age
- Anovulation Treatment
- Cervical Factor
- Definition
- Endometriosis
- Fibroids
- Investigations
- Male Factor
- IVF
- Prevalence
- Prognosis
- Smoking
- Support Groups
- Treatments
- Objectives
- Folic Acid
- Ovulation Induction
- Clomiphene
- HCG
- Tamoxifen
- Letrozole
- Hyperprolactinaemia
- Metformin PCOS
- Gonadotrophins
- Ovarian Hyperstimulation
- Ovarian Drilling
- Myomectomy
- Artifical Insemination
- Success Rates
- Pregnancy Outcomes
- Tubal Factor
- Unexplained
- Uterine Abnormality
- Medication Drugs
- Menopause
- Menorrhagia
- Miscarriage
- Painful Sex
- Pap Smear Test
- PCOS
- Pelvic Pain
- PMS
- Postpartum
- Pregnancy
- Self Esteem
- Sexual Problems
- Vaginal Discharge
- Vaginal Prolapse
- Vulval Symptoms
Underperforming Family Website?
Visit
KeywordSEOPro.com - SEO Keyword Tool and SEO Tips
Now
Promote Your
Family Website
Improve Your Business Income




